Orzax Unveils 2026 Roadmap with "THE FUTURE IS NOW" Theme

Orzax conducted a comprehensive review of 2025 and shared its strategic road map for 2026 with its teams at the year-end meeting held in the Turkish Republic of Northern Cyprus between 29 January and 1 February. At the event, organized under the theme "THE FUTURE IS NOW," the company's vision for its second 20 years, investment plans and growth targets were discussed in detail.
Orzax held its end-of-period meeting in the Turkish Republic of Northern Cyprus between 29 January and 1 February, conducting a comprehensive review of 2025 while sharing its strategic roadmap for 2026 with its teams. At the event held under the theme "THE FUTURE IS NOW," the company detailed its vision for its second 20 years, investment plans and growth targets.
At the meeting attended by Orzax's senior management, sales and marketing teams and central staff under the Alyors Group umbrella, sustainable success, systematic growth philosophy and team solidarity took centre stage.
Strong vision for the second 20 years
Selman Alimoğlu, Chairman of the Board of Alyors Group, opened the meeting by emphasizing that Orzax entered its new era not only with commercial scale but also as an exemplary structure through its corporate culture, human resources and long-term vision. He stated that behind the success achieved to date lay consistent management practices and a strong team acting with collective wisdom.

Orzax CEO Yunus Emre Alimoğlu described the company's development using the metaphor of a white lily, noting that they had grown with correct values and determination despite difficult conditions. Alimoğlu emphasized that the scale the company had reached now needed to be managed through data, systems and documented processes:
"Today Orzax is on a different scale. It is no longer enough to simply set targets; we must establish systems that define how we will reach those targets. Scale is carried into the future through systems, not intentions."

Target: Global impact
Alimoğlu noted that a journey begun 21 years ago with limited resources has transformed into industry leadership, and said that Orzax's natural direction from this point forward is to create impact on a global scale. Since 2018, the company has maintained its leadership position, continuing to pioneer OTC market development through product quality, strong relationships with healthcare professionals and contributions to public health literacy.
New brand identity: Transformation into a lifestyle brand
Müge Turan, Director of Marketing and Corporate Communications at Orzax, stated that in its second 20 years the brand would position itself not merely as a dietary supplement manufacturer but as a lifestyle brand offering a personalized health ecosystem. Turan expressed that they aimed to be a brand directed towards transformation with a global vision centred on science and innovation.
"The future is no longer something we await, but something we create together," said Turan, emphasizing that the "The Future is Now" approach was a shared call to action for all company teams.

New growth axis in dermocosmetics: Shiniq
At the meeting, the dermocosmetics division emerged as one of Orzax's new growth areas. While the company is transferring its 20-year scientific expertise to this field through the Shiniq brand, it aims to create differentiation in a market dominated by imported products through its vision of locally-produced, science-based manufacturing.
Products developed with prebiotic and postbiotic ingredients, clean formulations and high production standards are reaching consumers through the pharmacy channel. This step is expected to provide Orzax with a strong position in a market that has reached USD 50 billion in size globally.
Manufacturing and R&D investments continue
The company's manufacturing and R&D investments were also among the important topics of the new era. It was announced that a second factory in Istanbul with a monthly capacity of 3 million units will be brought gradually into operation by August. It was also stated that work continues on industrial production of probiotics and raw material synthesis from microalgae.
The factory to be founded in Kazakhstan in March is planned to produce 2.5 million units per month at full capacity.
"2026 will be the year of productivity"
In his closing remarks at the meeting, CEO Yunus Emre Alimoğlu drew attention to the new era's performance focus with the following words:
"Systems are ready, staff are ready. From this point on, it is about performance. The future is not a distant target; it is shaped by every step we take today. Now is the time to build a much stronger Orzax in the second 20 years."
The event themed "THE FUTURE IS NOW" concluded with sessions enhancing inter-team interaction and presentations sharing the new era vision.
Gallery








